EDGAR Filing Documents for 0001193125-03-077873

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001193125-03-077873

Filing Date

2003-11-12

Accepted

2003-11-12 11:18:06

Documents

Period of Report

2002-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM 10-Q	d10qa.htm	10-Q/A	19555
3	AMENDMENT NO. 1 TO THE RESEARCH AGREEMENT, JANUARY 16, 2001	dex103.htm	EX-10.3	10864
4	AMENDMENT NO. 2 TO THE RESEARCH AGREEMENT, MARCH 28, 2001	dex104.htm	EX-10.4	11597
5	AMENDMENT NO. 1 TO THE RESEARCH AGREEMENT, MARCH 18, 2002	dex105.htm	EX-10.5	12168
6	LICENSE AGREEMENT, AUGUST 31, 1994	dex106.htm	EX-10.6	83232
7	AMENDMENT NO. 1 TO LICENSE AGREEMENT, JUNE 19, 2000	dex107.htm	EX-10.7	22140
8	CERTIFICATION OF PRICIPAL EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A)	dex311.htm	EX-31.1	2463
9	CERTIFICATION OF PRICIPAL FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A)	dex312.htm	EX-31.2	2504
	Complete submission text file	0001193125-03-077873.txt		167201

Mailing Address 78 FOURTH AVENUE WALTHAM MA 02451

Business Address 78 FOURTH AVENUE WALTHAM MA 02451 (781) 647-5554

ESSENTIAL THERAPEUTICS INC (Filer) CIK: 0001010915 (see all company filings)